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Abstract
The inability to generate a voiding contraction sufficient to allow efficient
bladder emptying within a reasonable time frame is a common problem seen in
urological practice. Typically, the symptoms that arise are voiding symptoms,
such as weak and slow urinary flow. These symptoms can cause considerable
bother to patients and impact upon quality of life. The urodynamic finding of
inadequate detrusor contraction has been termed detrusor underactivity (DUA).
Although a definition is available for this entity, there are no widely accepted
diagnostic criteria. Drawing parallels to detrusor overactivity and the overactive
bladder, the symptoms arising from DUA have been referred to as the
“underactive bladder” (UAB), while attempts to crystallize the definition of UAB
are now ongoing. In this article, we review the contemporary literature
pertaining to the epidemiology and etiopathogenesis of DUA as well as discuss
the definitional aspects that are currently under consideration.
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Introduction
Detrusor underactivity (DUA) is a common bladder dysfunction 
observed in both men and women undergoing urodynamic stud-
ies for the assessment of lower urinary tract symptoms (LUTS). 
It is typically associated with voiding LUTS such as slow urinary 
flow and intermittency but may also result in storage and post- 
micturition LUTS. Despite being commonly encountered in rou-
tine clinical practice, DUA has been given relatively little attention 
in clinical and scientific research. Not only can DUA arise in 
bothersome symptoms but its occurrence may impact upon the 
outcome of treatments for other dysfunctions, such as bladder 
outlet obstruction and stress urinary incontinence. Recently, there 
has been renewed interest in DUA, the associated symptoms, and 
potential treatments. This article aims to review the recent litera-
ture regarding the epidemiology, etiopathogenesis, and diagnosis of 
DUA and its associated symptoms.
Definition
A plethora of terms have been used to describe a bladder that does 
not contract efficiently. Terms such as detrusor areflexia, hypotonic 
bladder, atonic bladder, detrusor failure, impaired detrusor contrac-
tility, and chronic retention all reflect the lack of consensus and 
uncertainty as to the pathophysiological mechanisms at play. In 
an effort to standardize terminology, the International Continence 
Society report in 2002 used the term DUA to describe a urody-
namic abnormality. This was defined as “a contraction of reduced 
strength and/or duration, resulting in prolonged bladder empty-
ing and/or failure to achieve complete bladder emptying within a 
normal time span”1. This definition is necessarily vague on specify-
ing the parameters for length and strength of contraction and pro-
longed voiding, as what is normal has not yet been established.
Signs and symptoms
There is a lack of prospective studies correlating DUA and its asso-
ciated clinical signs and symptoms. In clinical practice, the typical 
presentation is of voiding LUTS such as reduced flow, prolonged 
flow, hesitancy, and intermittency. After voiding, some patients may 
report a sensation of incomplete bladder emptying, which may be 
related to a raised post-voiding residual (PVR).
One could speculate that the presence of storage symptoms is 
related to the bladder sensory function in the individual patient, 
such that patients with poor or absent bladder sensation will have 
a reduced urge to pass urine, which will result in infrequent void-
ing. Anecdotally, some patients may report they lack any percep-
tion of their bladder emptying during the voiding process. Should 
these patients retain a large enough PVR, they may also experience 
incontinence, particularly during the night. This clinical picture is 
commonly termed chronic urinary retention (CUR). Patients with 
retained bladder sensation may void with a normal frequency pat-
tern or have increased frequency, nocturia, and incontinence should 
the PVR be high enough.
There has been some debate about whether a symptom complex is 
associated with DUA, referred to by some as the underactive blad-
der (UAB), which is rather analogous to detrusor overactivity (DO) 
and the overactive bladder (OAB) symptom complex. This is cer-
tainly an attractive concept, as it could, in theory, allow patients to 
be diagnosed and treated on the basis of symptomatology. Never-
theless, there are clear difficulties in defining a specific set of symp-
toms that do not overlap significantly with LUTS due to benign 
prostatic enlargement (BPE). Clearly in women this is less likely 
to be problematic given the relatively rare occurrence of obstruc-
tive causes. A working definition for UAB was recently proposed 
by an expert consensus group: “…a symptom complex suggestive 
of detrusor underactivity and is usually characterised by prolonged 
urination time with or without a sensation of incomplete bladder 
emptying, usually with hesitancy, reduced sensation on filling, and 
a slow stream”2.
Epidemiology
Given the inability to diagnose DUA without an invasive urody-
namic study, it is unsurprising that there is little information on its 
prevalence on a population basis. There is no single non-invasive 
proxy measure (e.g. raised PVR, reduced urinary flow rate) that 
could reliably identify patients with the condition. Clinical series of 
patients with LUTS undergoing urodynamic studies offer the best 
available evidence as to the prevalence of DUA. In younger men 
(<50 years), prevalence is 9–28%, which rises to 48% in elderly 
men (>70 years)3. In elderly women, prevalence rates are between 
12 and 45% and peak in the institutionalized elderly. Older frail 
patients often have co-existent DO, and this entity was originally 
described by Resnick and co-workers in 1987 as detrusor hyperac-
tivity impaired contractility (DHIC)4.
Etiopathogenesis
Given the diverse patient groups who can be affected by DUA, it is 
clear that the etiopathogenesis is likely to be multi-factorial. There 
seems to be an assumption in the literature that aging leads to a 
decline in detrusor contractile function. While plausible, it must be 
emphasized that there is no conclusive evidence that this is the case. 
The available data from animal and human studies is often quite 
contradictory.
The etiological factors resulting in DUA can be broadly classified 
as neurogenic or myogenic.
Myogenic factors
Any pathological process that changes the normal structure and/or 
functioning of the extracellular matrix or the myocytes of the 
detrusor may cause a loss in the generation or transmission of a 
contraction. Factors that may affect the contractile activity of the 
myocytes include disruption of important cellular mechanisms 
(e.g. ion storage/exchange, excitation-contraction coupling, cal-
cium storage, and energy generation). The implication of this is that 
even if efferent neuronal activity is normal, an impaired contraction 
will result5.
Supporting the idea that myogenic factors may be important, mor-
phological changes have been observed within both the normally 
aged and the diseased detrusor. Much of this work was conducted 
by Elbadawi, who suggested that specific ultrastructural features 
detected by electron microscopy were associated with aging and 
different bladder dysfunctions including DUA6–8. The specific pat-
tern associated with DUA was described as the “degeneration” pat-
tern, characterized by widespread disrupted myocytes with axonal 
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degeneration6. What is not clear is whether detrusor myocyte dis-
ruption is in itself the cause of DUA or the result of an underlying 
pathological process.
Neurogenic factors
Intact bladder sensation is central to the voiding reflex. The affer-
ent nerves monitor bladder volume during the storage phase and 
also during the voiding phase. Afferent nerves arising at the level 
of the urethra may also have a contributory role in perceiving flow 
through the urethra9,10. If afferent functioning is reduced, this may 
lead to a reduction in the strength or premature termination of the 
voiding reflex11.
Bladder outlet obstruction
It has long been held that DUA occurs as a secondary effect of 
prolonged bladder outlet obstruction (BOO). This assumption has 
been largely derived from work in animals, particularly the rodent, 
where partial BOO is induced by a constricting metal ring or liga-
ture. The process by which DUA occurs has been widely described 
and includes three phases12,13:
1.   Following obstruction, there is increased bladder outlet 
resistance leading to bladder wall distension
2.   Compensatory hypertrophy and hyperplasia of the detrusor 
then occurs associated with a rise in tissue blood supply
3.   Initially, contractile function is maintained; however, after 
a variable period of time, contractility is dissipated with a 
reduction in bladder emptying ability (decompensation)
Relating the insights from this work to humans is problematic, as 
the animals studied are usually young and female with an acute 
obstruction induced using a constricting ring. This is unlikely to be 
a good representation of the common clinical scenario of an elderly 
man with compressive benign prostatic obstruction. Interestingly, 
the largest longitudinal study available has shown that in man, pro-
longed BOO does not usually result in decompensation and DUA. 
In a group of 170 men with BOO demonstrated on pressure-flow 
studies, no significant deterioration in urodynamic parameters 
was observed at a mean follow up of 13.9 years (no change in 
pdet@Qmax [detrusor pressure at maximum flow] and a reduction 
in Qmax [maximum flow rate] of only 1 ml/s)14.
Diabetes mellitus
Diabetic bladder dysfunction (DBD) (or diabetic cystopathy) is a 
well-recognized cause of DUA. Diabetes mellitus probably affects 
function through both a myogenic and a neurogenic mechanism 
leading to a decline in bladder emptying ability throughout the 
course of the disease15,16. It is traditionally thought that this pre-
dominately occurs through hyperglycemia-induced axonal degen-
eration and segmental demyelination leading to impaired afferent 
and efferent bladder function (autonomic neuropathy)17. Myogenic 
mechanisms are less clearly elucidated, though it is likely that 
changes in intercellular connections and excitability, intracellular 
signaling, and receptor density and distribution are implicated18.
Diagnostic aspects
Currently, the only accepted modality for diagnosing DUA is an 
invasive pressure-flow test (or urodynamic study). However, there 
are no widely accepted criteria for diagnosing DUA. Most proposed 
methods relate to the measurement of the strength of the detrusor 
contraction.
Detrusor contraction strength
A detrusor contraction generates pressure and flow19; therefore, 
many authors have used two measurements to approximate con-
traction strength and thereby diagnose DUA: the maximal flow 
(Qmax) and the detrusor pressure at maximal flow (Pdet@Qmax). 
Most often a reduction in either is considered to be lower than the 
“normal” range. Historically, for men the normal ranges are derived 
from a series of men undergoing de-obstructive surgery20,21. In 
other groups, such as healthy men and women, in particular, the 
ranges are less well established22–24. Although relatively simple to 
apply, this method has two flaws. Firstly, it is likely to be an inac-
curate method of determining the maximal pressure generated by 
the bladder due to the bladder outlet relation (BOR), the normal 
inverse correlation between detrusor pressure and urine flow during 
voiding25. Essentially, the BOR can be summed up as during void-
ing the pressure is highest when flow is lowest and vice versa, hence 
the pdet@Qmax represents the point of lowest bladder pressure 
during voiding. Secondly, the fact that the flow rate is also impacted 
upon by the degree of bladder outlet resistance is not considered. 
This is important because when detrusor pressure is low, the cause 
of low flow may also have its basis in obstruction (e.g. due to BPE) 
or alternatively a normal Qmax can result from reduced outlet 
resistance even if detrusor pressure is low (e.g. post-prostatectomy 
incontinence).
In order to gain a more accurate assessment of contraction strength, 
different methods of measuring isovolumetric bladder pressure 
have been introduced:
1. Watts factor
This is an estimate of the power per unit area of the bladder sur-
face that is generated by the detrusor. The formula for calculation is 
WF = [(pdet + a) (vdet + b) – ab]/2π where vdet is detrusor 
shortening velocity and a and b are fixed constants (a=25 cmH2O, 
b=6 mm/s) derived from experimental and clinical data26. The main 
pros of the WF are that it is not dependent on bladder volume26 and is 
not influenced by increased outlet resistance27. There are, however, 
no validated values for what is considered normal. Currently, the WF 
is little used in practice due to its complexity as well as the fact that it 
assesses only strength of contraction, rather than duration.
2. Projected isovolumetric pressure (PIP)
The PIP was proposed by Schäfer, who used a straight line to rep-
resent the BOR and then “projected” back to the y-axis (pdet) from 
the point representing pdet@Qmax to obtain the isovolumetric 
pressure. This projection is calculated by the formula PIP = Pdet@
Qmax + KQmax where K is a fixed constant representing the steep-
ness of the angle of the BOR to x-a axis28. K is dependent on the 
specific population studied and differs between men and women29; 
in men it is usually taken as 5. The suggested groupings for PIP are 
as follows:
•    >150 − strong contractility
•    100 to 150 − normal contractility
•    50 to 100 − weak contractility
•    <50 − very weak contractility
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There are two other reported variants of the PIP: the detrusor coef-
ficient (DECO), which is the PIP divided by 100, and the bladder 
contractility index (BCI), which is essentially the same as PIP but 
with different groupings. The main advantage with these formulae 
is that they are easy and quick to use; however, they may over-
estimate PIP and have less test-retest reliability than measuring 
isovolumetric pressures directly30.
3. Mechanical occlusion of flow
This entails the direct measurement of isovolumetric pressure by 
the mechanical obstruction of urine flow31. There are two methods 
for this measurement: (1) a stop test, the interruption of flow once 
it has already started, or (2) continuous occlusion test, where urine 
flow is impeded before and throughout the duration of the detrusor 
contraction. Stop tests can be voluntarily induced by the patient 
by contraction of the rhabdosphincter or alternatively the urody-
namicist can impede flow through methods such as manual occlu-
sion of the urethra. The voluntary stop test tends to underestimate 
pressure by about 20 cmH2O, which is likely to be attributable to 
a reflex detrusor inhibition brought on by sphincter contraction30,32. 
The voluntary test may not be possible in patients with sphincter 
weakness and in the elderly, whereas continuous occlusion can be 
painful and does not provide the opportunity for synchronous flow 
measurement.
Detrusor contraction speed
If a bladder is slow to contract, then this could also potentially 
result in DUA. Cucchi and co-workers proposed the parameter of 
detrusor shortening velocity, as calculated by the formula vdet = 
Q/2[3/(V + Vt)/4π]0.66 where Q represents the flow rate (ml/s), 
V represents bladder volume (ml), and Vt represents the volume of 
non-contracting bladder wall tissue. They found that a reduction in 
shortening velocity was evident before a decline in Watt factor in 
both men33,34 and women35.
Ambulatory urodynamics
It is not uncommon for a patient to be unable to void during a 
urodynamic study due to anxiety; this has been termed “bashful 
bladder”, which has been attributed to inadequate relaxation of 
the rhabdosphincter combined with reflex detrusor inhibition. This 
situation is usually identified by taking a good clinical history of 
previous voiding symptoms; however, if doubt persists, then an 
ambulatory urodynamic study may be helpful36,37.
Conclusions
DUA remains a poorly characterized and poorly understood blad-
der dysfunction. Its clinical correlate, UAB, has recently been 
introduced into clinical usage, yet it remains unclearly defined. 
To progress the current situation, there is a need to investigate the 
common mechanisms by which patients develop DUA as well as to 
collect prospective data that can be used to correlate the symptoms 
and signs with an underlying urodynamic abnormality.
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The short commentary ‘The underactive bladder: detection and diagnosis’ discusses the topic from the
perspective of symptoms, epidemiology, pathogenesis, and diagnostic aspects. The paragraphs on
diagnostic aspects are a summary of urodynamic testing, more specifically: pressure-flow analysis. I
assume that the words ‘…are typically associated with…’ in the introduction and the words ‘…typical
presentation…’ in the signs and symptoms section, refer to the historical beliefs of professionals. The last
paragraph of the signs and symptoms section mentions that there is a debate on whether there is a
symptom complex associated with detrusor underactivity (the underactive bladder syndrome?). I agree
with this statement and careful reading of the working definition cited from reference 2 in the commentary
makes it obvious that the working definition of (the) bladder outflow obstruction (syndrome) would be
exactly identical, if it was introduced nowadays. The elements of the working definition for UAB (as a
signs and symptoms syndrome) are equal to those considered, both currently and traditionally, very
relevant in men with benign prostatic enlargement . I conclude that the underactive bladder syndrome as
it is suggested here is not specific, like all LUTD-syndromes, and that, indeed, underactive detrusor
(contraction during voiding) is a condition only assessable with a pressure-flow study.
There is some observational clinical data on how the detrusor compensates for the growing prostate and
the–by consequence–increase in bladder outflow obstruction, in addition to the animal studies referred to
in the commentary, to explain the pathophysiology . With the perspective of DU, this clinical study may
allow two interpretations; first: the detrusor of aging men increases (maximum) power to compensate for
the growing prostate and second: some detrusors are better able to compensate than others. The validity
of the clinical observation  was subsequently confirmed in a canine experiment . If relevant neurogenic
abnormalities are excluded on the basis of history and clinical examination, myogenic factors remain as
the cause of detrusor underactivity, and based on biologic variance, some detrusors will be stronger than
others and some will be better able to conquer challenges. The search for relevant amino-acids or other
molecules will be important here if we want to discover ways to improve the symptomatically weak
detrusors.
Urodynamic diagnosis of detrusor contraction work or power during voiding is not yet standardized, and
the commentary gives a neat overview of parameters that may prove to be useful. Especially objective
parameters that will demonstrate predictive value and responsiveness to management will become
relevant in the future.
Cooperation with the patient is necessary to obtain a representative pressure-flow test, and the autonomic
voiding reflex requires parasympathetic dominance in a–for the patient involved–stressful situation. This is
1
2
2 3
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voiding reflex requires parasympathetic dominance in a–for the patient involved–stressful situation. This is
even more important when the patient has a ‘bashful bladder’. I consider it valuable that this is introduced
here in this context. Based on the relevance of this dysfunction, that will exist in a continuum from ‘low
grade’ to ‘very troublesome‘, the new ICS Good Urodynamic Practices and Terms (that will be available in
2016) will introduce the terms (or diagnoses) ‘situational inability to void’ and ‘situational inability to void
as usual’. Whether ambulatory urodynamics provides a reliable method to obtain a pressure-flow test
remains speculative however, because of the lack of evidence.
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